Proposed Nasdaq symbol INAB. Business: Phase 1 oncology biotech developing allogeneic gamma-delta T cell therapies. Most Popular. Nevada is ...
News
- Initial public offerings scheduled to debut next week
- GlycoMimetics: 3Q Earnings Snapshot
The biotechnology company posted revenue of $1 million in the period. The company's shares closed at $3.05. A year ago, they were trading at $5.84.
- Global Respiratory Virus Vaccines Market,Top key players @ CSL Limited, Bharat Biotech, Sanofi ...
Top key players @ CSL Limited, Bharat Biotech, Sanofi, AstraZeneca, GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., ... 1604 W San Antonio,.
- Global Cancer mTOR Inhibitors Market,Top key players @ Abraxis BioScience, Adimab, Celgene ...
Top key players @ Abraxis BioScience, Adimab, Celgene Corporation, Celator Pharmaceuticals, Eli Lilly, Exelixis, ... 1604 W San Antonio,. TX 78249.
- Business Is Booming For San Antonio's Virus-Killing Robot Company
Texas Biomed in San Antonio successfully tested the robot against the virus in April of this year. The robot is regulated by the Environmental Protection ...